Ong, S Tiong
Duke University · Singapore General Hospital · Duke Medical Center · Duke-NUS Medical School
3 papers on CoChatORCID 0000-0001-9460-3483
Most cited papers
- Verified
A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer
Ng, K. P., Hillmer, A. M., Chuah, C. T. H., Juan, W. C., Ko, T. K., Teo, A. S. M., Ariyaratne, P. N., Takahashi, N., Sawada, K., Fei, Y., et al. (2012) · Nature Medicine
Cell death mechanisms and regulationLung Cancer Treatments and Mutations
Cited by 557
- Verified
Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia
on behalf of the International CML Foundation Genomics Alliance, Branford, S., Kim, D. D. H., Apperley, J. F., Eide, C. A., Mustjoki, S., Ong, S. T., Nteliopoulos, G., Ernst, T., Chuah, C., et al. (2019) · Leukemia
Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research
Cited by 149
- Verified
A Single-Cell Atlas Identifies Pretreatment Features of Primary Imatinib Resistance in Chronic Myeloid Leukemia
Krishnan, V., Schmidt, F., Nawaz, Z., Lee, K. L., Nori Venkatesh, P., Makheja, M., Chan, Z. E., Yu, M., Arul Rayan, N., Gek Liang Lim, M., et al. (2022) · Blood
Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research
Cited by 15
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free